-
Gastrodin Capsules
Greatly Increased Absorption of Gastrodin and Improved Sedation and Analgesic Efficacy.
The production of synthetic gastrodin was a major landmark and has been hailed as a “model of traditional Chinese medicine manufactured in a modern way”. In 1994, the Gastrodin Capsule became available, and as a light-weight sedative and analgesic that can be taken orally, it has an obvious effect in the treatment of dizziness and headaches. It is safe to take on a long-term basis.
-
Acetagastrodin Tablets
Safe and Preferred Medicine to Treat Anxiety and Depression.
During the process of synthesis of gastrodin, it was discovered that the sedation index of acetagastrodin obtained by modification of the structure of gastrodin is 1.77 times higher than that of gastrodin due to the fact that it is obviously more liposoluble than gastrodin. It is an effective medicine for the treatment of neurasthenic syndrome.
-
Gastrodin Tablets
Effective Medicine for Sedation, Analgesic and Hypnosis with More Than 30 Years of Clinical Application.
Gastrodin Tablets’ were the first available gastrodin monomer preparations on the market. Over 30 years of application, Gastrodin Tablets have become well known by patients as effective medicine for sedation, analgesic and hypnosis. Long-term use of Gastrodin Tablets will not produce drug dependence and habituation, making it a safe choice.
-
Tianxuanqing® Gastrodin Injection
The First Approved Gastrodin Preparation Used for Intravenous Injection.
The only domestic gastrodin injection which have been through Phase I and Phase II clinical trials based on GCP (Good Clinical Trial Practice). In 2003-2004, KPC conducted Phase I and Phase II clinical trials for its Gastrodin Injection for the treatment of vertigo by giving the medicine intravenously at the West China Hospital, SCU, First Affiliated Hospital of Chongqing Medical University, and the Southwest Hospital Affiliated to the Third Military Medical University. The clinical trials results showed that the Gastrodin Injection is effective for the treatment of vertigo (with an efficacy ratio of 90.6%). At this point, KPC’s Tianxuanqing Gastrodin Injection became the first gastrodin injection approved for intravenous administration in China.
